Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
American Journal of Clinical Oncology|April 7, 2021
Impact of Use of Antibiotics on Response to Immune Checkpoint Inhibitors and Tumor MicroenvironmentUqba Khan, Kaylee Ho, Eun Kyeong Hwang, et al.
Pathology, Research and Practice|July 31, 2025
Integrative transcriptomic and single-cell protein characterization of colorectal carcinoma delineates distinct tumor immune microenvironments associated with overall survivalErika Hissong, Bhavneet Bhinder, Junbum Kim, et al.
Research Square|August 7, 2024
Integrative Transcriptomic and Single-Cell Protein Characterization of Colorectal Carcinoma Delineates Distinct Tumor Immune Microenvironments Associated with Overall SurvivalErika Hissong, Bhavneet Bhinder, Junbum Kim, et al.
Journal for Immunotherapy of Cancer|June 16, 2022
Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched studyBrett Marinelli, Edward Kim, Antonio D'Alessio, et al.
Journal for Immunotherapy of Cancer|September 2, 2020
Post-registration experience of nivolumab in advanced hepatocellular carcinoma: an international studyPetros Fessas, Ahmed Kaseb, Yinghong Wang, et al.
Therapeutic Advances in Medical Oncology|May 17, 2021
Antacid exposure and immunotherapy outcomes among patients with advanced hepatocellular carcinomaTomi Jun, Umut Ozbek, Sirish Dharmapuri, et al.
Cancers|July 16, 2020
Immunotherapy in Hepatocellular Cancer Patients with Mild to Severe Liver Dysfunction: Adjunctive Role of the ALBI GradeDavid J Pinato, Takahiro Kaneko, Anwaar Saeed, et al.
Oncogene|September 21, 2023
Neoadjuvant botensilimab plus balstilimab response pattern in locally advanced mismatch repair proficient colorectal cancerPashtoon Murtaza Kasi, Manuel Hidalgo, Mehraneh D Jafari, et al.
Journal for Immunotherapy of Cancer|October 8, 2020
Impact of corticosteroid therapy on the outcomes of hepatocellular carcinoma treated with immune checkpoint inhibitor therapyDavid J Pinato, Ahmed Kaseb, Yinghong Wang, et al.
Hepatology Communications|April 28, 2022
Patterns and outcomes of subsequent therapy after immune checkpoint inhibitor discontinuation in HCCRohini Sharma, Anjana Pillai, Thomas Urban Marron, et al.
Pageof 4